Lupa

Iskanje po repozitoriju Pomoč

A- | A+ | Natisni
Iskalni niz: išči po
išči po
išči po
išči po
* po starem in bolonjskem študiju

Opcije:
  Ponastavi


171 - 180 / 220
Na začetekNa prejšnjo stran13141516171819202122Na naslednjo stranNa konec
171.
172.
173.
174.
175.
Poročilo raziskave med tekači in tekačicami
Eva Podovšovnik, Miha Lesjak, 2015, objavljeni strokovni prispevek na konferenci (vabljeno predavanje)

Ključne besede: maraton, Istra, športne prireditve
Objavljeno v RUP: 15.10.2015; Ogledov: 3492; Prenosov: 63
URL Povezava na celotno besedilo

176.
Športni turizem in vplivi velikih športnih prireditev na lokalno skupnost
Miha Lesjak, 2014, samostojni znanstveni sestavek ali poglavje v monografski publikaciji

Ključne besede: turizem, športni turizem, lokalno prebivalstvo
Objavljeno v RUP: 15.10.2015; Ogledov: 4772; Prenosov: 352
URL Povezava na celotno besedilo

177.
178.
Ergo-Cell : a multi-sensor system offering new opportunities for research in elderly
Nejc Šarabon, Miha Peroša, Jure Pražnikar, Helmut Kern, 2015, objavljeni povzetek znanstvenega prispevka na konferenci

Ključne besede: measurements, mobile technology, physiology, ergonomics
Objavljeno v RUP: 15.10.2015; Ogledov: 3126; Prenosov: 38
URL Povezava na celotno besedilo

179.
Endoglin (CD105) silencing mediated by shRNA under the control of Endothelin-1 promoter for targeted gene therapy of Melanoma
Nataša Tešić, Urška Kamenšek, Gregor Serša, Simona Kranjc Brezar, Monika Savarin, Urša Lampreht Tratar, Véronique Préat, Gaëlle Vandermeulen, Miha Butinar, Boris Turk, Maja Čemažar, 2015, izvirni znanstveni članek

Opis: Endoglin (CD105), a transforming growth factor (TGF)-% coreceptor, and endothelin-1, a vasoconstrictor peptide, are both overexpressed in tumor endothelial and melanoma cells. Their targeting is therefore a promising therapeutic approach for melanoma tumors. The aim of our study was to construct a eukaryotic expression plasmid encoding the shRNA molecules against CD105 under the control of endothelin-1 promoter and to evaluate its therapeutic potential both in vitro in murine B16F10-luc melanoma and SVEC4-10 endothelial cells and in vivo in mice bearing highly metastatic B16F10-luc tumors. Plasmid encoding shRNA against CD105 under the control of the constitutive U6 promoter was used as a control. We demonstrated the antiproliferative and antiangiogenic effects of both plasmids in SVEC4-10 cells, as well as a moderate antitumor and pronounced antimetastatic effect in B16F10-luc tumors in vivo. Our results provide evidence that targeting melanoma with shRNA molecules against CD105 under the control of endothelin-1 promoter is a feasible and effective treatment, especially for the reduction of metastatic spread.
Ključne besede: melanoma, electroporation, endoglin (CD105), endothelin-1, gene therapy
Objavljeno v RUP: 14.10.2015; Ogledov: 3823; Prenosov: 131
URL Povezava na celotno besedilo

180.
Iskanje izvedeno v 0.12 sek.
Na vrh
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici